The 2023-2027 Market Prognosis Global report is now available.
In this release, discover:
- Why Global pharmaceutical sales will accelerate to a CAGR of 7.8% in 2022-2027 - to reach US$2.1 trillion by 2027 - as new product launches drive up pharmaceutical spending in spite of continued cost-containment measures to curb expenditure
- The challenges and opportunities for the Major Developed markets as they deal with rising healthcare costs, rapidly ageing populations, and ever-increasing pressure to improve access to innovative drugs
- The shift in contributions to aggregate market growth among the Pharmerging markets, as growth in some smaller markets accelerates, while growth in several major markets slows
- How the prolonged Russia-Ukraine conflict is expected to shape the CIS region’s pharmaceutical market landscape over the next five years
- The outlook for the Latin American pharmaceutical markets amidst heightened economic and political uncertainty and growing healthcare demands fuelled by epidemiological and demographic trends, as well as the deterioration of the population’s health status caused by the COVID-19 pandemic
- How the pharmaceutical markets in the South-East & East Asia region will experience solid growth propelled by medical tourism, expanding health insurance coverage, and wider access to innovative drugs in the backdrop of increasing pricing pressure and cost-containment measures in the region
Want to find out how Market Prognosis insights and forecasts can help you better understand challenges and opportunities in your markets? Please fill out the form and we will be in touch.
